As we have already mentioned in the introduction, numerous researchers and clinicians have tried to use the mutation status of TP53 and p53 protein amounts as prognostic markers for pancreatic adenocarcinoma for a long time. Here, TP53 is linked to pancreatic adenocarcinoma.